Brave Asset Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Brave Asset Management’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-24,000	Closed	-$49K	–	453
2016 Q1	$49K	Sell	24,000 -2,000	-8%	-$3.57K	0.03%	216
2015 Q4	$64K	Sell	26,000 -2,000	-7%	-$5.93K	0.04%	203
2015 Q3	$73K	Buy	28,000 +15,500	+124%	+$40.4K	0.06%	184
2015 Q2	$39K	Hold	12,500	–	–	0.03%	244
2015 Q1	$36K	Sell	12,500 -5,000	-29%	-$12.8K	0.03%	253
2014 Q4	$45K	Buy	17,500 +11,500	+192%	+$50.3K	0.03%	236
2014 Q3	$45K	Buy	6,000 +1,000	+20%	+$9.34K	0.03%	229
2014 Q2	$59K	Buy	5,000 +1,000	+25%	+$10.7K	0.04%	207
2014 Q1	$46K	Buy	+4,000	New	+$47.1K	0.04%	226

Brave Asset Management's SZYM Position: Q2 2016 in Review

Brave Asset Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 24,000 shares — an estimated $49K sold.

Brave Asset Management first reported a position in SZYM in Q1 2014 and held it in 9 quarters. The position peaked at $73K in Q3 2015. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

Brave Asset Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
Brave Asset Management sold 24,000 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $49K.
Brave Asset Management first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 9 quarters.
Brave Asset Management's SOLAZYME INC COM STK (DE) position peaked at $73K in Q3 2015.
0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Brave Asset Management's 13F filing for Q2 2016, filed 9 Aug 2016.